REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 131 filers reported holding REVOLUTION MEDICINES INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $45,140 | -99.9% | 1,895,066 | -5.0% | 3.02% | +9.9% |
| Q3 2022 | $39,343,000 | +1.2% | 1,995,066 | 0.0% | 2.75% | -6.5% |
| Q2 2022 | $38,884,000 | -23.6% | 1,995,066 | 0.0% | 2.94% | -24.8% |
| Q1 2022 | $50,894,000 | -16.9% | 1,995,066 | -18.0% | 3.91% | +7.3% |
| Q4 2021 | $61,210,000 | -29.2% | 2,431,852 | -22.7% | 3.64% | +3.6% |
| Q3 2021 | $86,511,000 | -18.3% | 3,144,700 | -5.8% | 3.52% | -2.3% |
| Q2 2021 | $105,953,000 | -8.5% | 3,338,166 | +32.2% | 3.60% | +39.4% |
| Q1 2021 | $115,847,000 | +17.3% | 2,525,000 | +1.2% | 2.58% | +9.8% |
| Q4 2020 | $98,780,000 | +7.5% | 2,495,066 | -5.5% | 2.35% | -33.5% |
| Q3 2020 | $91,878,000 | +11.0% | 2,640,177 | +0.1% | 3.53% | +11.9% |
| Q2 2020 | $82,737,000 | +36.5% | 2,636,661 | -4.7% | 3.16% | +12.1% |
| Q1 2020 | $60,627,000 | – | 2,767,078 | – | 2.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |